Specific immunotherapy positively influences the clinical course of pollynosis with rhinoconjuctival and bronhspastical syndrome. Its efficiency increases with its duration, improves immunity indices.
Specific immunotherapy positively influences the clinical course of pollynosis with rhinoconjuctival and bronhspastical syndrome. Its efficiency increases with its duration, improves immunity indices.